Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Descending Price Range
May 6, 2013 vagelos p roy Officer Sell 13,482 263.15 - 264.19
May 6, 2013 tessier-lavigne marc Director Sell 13,334 260.20 - 264.17
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Nov 5, 2007 brown michael s Director Automatic Sell 13,292 20.31 - 20.66
Apr 19, 2012 baker charles a Director Automatic Sell 12,910 125.00
Apr 19, 2012 baker charles a Director Option Execute 12,910 18.80
Feb 18, 2014 terifay robert j Officer Sell 12,865 331.66 - 333.79
Oct 10, 2011 terifay robert j Officer Automatic Sell 12,786 64.78
Jan 6, 2010 goldberg murray a Officer Automatic Sell 12,708 24.76 - 25.06
Jan 6, 2011 goldberg murray a Officer Automatic Sell 12,627 33.79
Dec 17, 2010 vagelos p roy Director Automatic Sell 12,616 32.06
May 13, 2013 aberman michael s Officer Option Execute 12,500 24.00
Apr 30, 2012 aberman michael s Officer Option Execute 12,500 24.00
Jun 3, 2010 kolinski stuart Officer Option Execute 12,500 8.50
Dec 28, 2009 roberts william Officer Automatic Sell 12,500 23.99
Dec 28, 2009 roberts william Officer Option Execute 12,500 8.50
Feb 2, 2010 kolinski stuart Officer Option Execute 12,314 8.50
Jul 27, 2011 goldberg murray a Officer Automatic Sell 12,258 53.18
Nov 2, 2009 brown michael s Director Disposition (Non Open Market) 12,000 n/a
Feb 2, 2010 roberts william Officer Option Execute 12,000 13.00
Showing 361-380 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)